Patents by Inventor FREDERIC BARABE

FREDERIC BARABE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-S100A8 for treating leukemia
    Patent number: 10894082
    Abstract: The present description relates to an anti-S1008 protein for treating leukemia. More specifically, is disclosed anti-S100A8 antibody that specifically binds to a portion of S100A8 protein and/or a S100A8/S100A9 heterodimer for treating leukemia.
    Type: Grant
    Filed: September 13, 2016
    Date of Patent: January 19, 2021
    Assignee: UNIVERSITÉ LAVAL
    Inventors: Philippe Tessier, Malika Laouedj, Frédéric Barabe, Natalie Pagé
  • Biomarkers for acute myeloid leukemia
    Patent number: 10501802
    Abstract: Methods for the diagnosis of leukemias, and more specifically AML, such as MLL-AF9 AML, in a subject, based on the assessment of the expression or activity of one or more of the genes listed in Tables 1 and 2 are disclosed. The use of antibodies or antigen-binding fragments thereof that bind to one or more of proteins showing preferential expression at the cell surface of AML leukemic cells for treating AML is also disclosed.
    Type: Grant
    Filed: April 30, 2014
    Date of Patent: December 10, 2019
    Assignees: UNIVERSITE DE MONTREAL, UNIVERSITÉ LAVAL
    Inventors: Brian Thomas Wilhelm, Frederic Barabe
  • ANTI-S100A8 FOR TREATING LEUKEMIA
    Publication number: 20180256710
    Abstract: The present description relates to an anti-S1008 protein for treating leukemia. More specifically, is disclosed anti-S100A8 antibody that specifically binds to a portion of S100A8 protein and/or a S100A8/S100A9 heterodimer for treating leukemia.
    Type: Application
    Filed: September 13, 2016
    Publication date: September 13, 2018
    Applicants: UNIVERSITÉ LAVAL, UNIVERSITÉ LAVAL
    Inventors: Philippe TESSIER, Malika LAOUEDJ, Frédéric BARABE, Natalie PAGÉ
  • NOVEL BIOMARKERS FOR ACUTE MYELOID LEUKEMIA
    Publication number: 20160060709
    Abstract: Methods for the diagnosis of leukemias, and more specifically AML, such as MLL-AF9 AML, in a subject, based on the assessment of the expression or activity of one or more of the genes listed in Tables 1 and 2 are disclosed. The use of antibodies or antigen-binding fragments thereof that bind to one or more of proteins showing preferential expression at the cell surface of AML leukemic cells for treating AML is also disclosed.
    Type: Application
    Filed: April 30, 2014
    Publication date: March 3, 2016
    Inventors: BRIAN THOMAS WILHELM, FREDERIC BARABE